175 results on '"DeWolf, Susan"'
Search Results
2. IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model
3. Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
4. SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
5. Low Kit expression identifies Hematopoietic Stem Cell subsets with enhanced lymphoid potential in mice and humans
6. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease
7. Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant
8. Early expansion of donor-specific Tregs in tolerant kidney transplant recipients
9. SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study
10. Figure S2 from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
11. Supplementary Tables from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
12. Data from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
13. Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy
14. CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
15. Siplizumab selectively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro
16. Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study
17. SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)
18. A High-Fiber Dietary Intervention (NUTRIVENTION) in Precursor Plasma Cell Disorders Improves Disease Biomarkers and Delays Progression to Myeloma
19. Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
20. Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
21. Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy
22. Leucine zipper-based sorting system enables generation of multi-functional CAR T cells
23. Cross-reactive public TCR sequences undergo positive selection in the human thymic repertoire
24. What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?
25. Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
26. Alloimmune T cells in transplantation
27. Tracking Immune Reconstitution in the Bone Marrow Following Allogeneic Hematopoietic Transplantation in Humans Reveals Early Dominance of Innate Lymphoid Populations
28. Outcomes and Management of Sars-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and CAR-T Therapy
29. TCRi: Information theoretic metrics for single cell RNA and TCR sequencing in cancer
30. SARS-CoV-2 in immunocompromised individuals
31. MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT
32. Triple Antigen mRNA-Loaded Langerhans-Type Dendritic Cell Vaccine after Autotransplant for Multiple Myeloma Induces Antitumor Immunity
33. Tissue-Specific Landscape of the Human T Cell Repertoire in Graft-Versus-Host Disease
34. Age-related epithelial defects limit thymic function and regeneration
35. Long-term CD4 lymphopenia is associated with accelerated decline of kidney allograft function
36. MAIT and Vδ2 Unconventional T Cells Predict Favorable Outcome after Allogeneic HCT and Are Supported By a Diverse Intestinal Microbiome
37. Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
38. Mucormycosis: New Developments into a Persistently Devastating Infection
39. CD8
40. Low CD117 Expression Identifies Hematopoietic Stem Cell Subsets with Enhanced Lymphoid Potential in Mice and Humans
41. Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study
42. Recirculating Regulatory T Cells Mediate Thymic Regeneration in a ZFP36L1 and Amphiregulin Dependent Manner
43. Higher CD4+ T Cell Counts after CAR-T in Large B-Cell Lymphomas Are Significantly Associated with Better Overall Survival
44. TCR Repertoires in Graft-Versus-Host-Disease (GVHD)-Target Tissues Reveals Tissue Specificity of the Alloimmune Response
45. CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer
46. Clinical Outcomes of Acute Myeloid Leukemia Patients Bridged to Allogeneic Stem Cell Transplant By Venetoclax Combination Therapy
47. How I treat relapsed or refractory AML
48. Atypical Presentation of Erythroid/Megakaryocytic Leukemic Transformation of a Myeloproliferative Neoplasm Associated with Mutation and Loss of TP53
49. 283 - Triple Antigen mRNA-Loaded Langerhans-Type Dendritic Cell Vaccine after Autotransplant for Multiple Myeloma Induces Antitumor Immunity
50. Quantifying size and diversity of the human T cell alloresponse
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.